NCT04748614

Brief Summary

In our study, we aimed to compare the average length of stay, death rates and costs of intensive care patients in October-November-December 2019 (before COVID 19) and October-November-December 2020 (during COVID 19).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 10, 2021

Completed
5 days until next milestone

Study Start

First participant enrolled

February 15, 2021

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2021

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2021

Completed
Last Updated

February 10, 2021

Status Verified

February 1, 2021

Enrollment Period

28 days

First QC Date

February 8, 2021

Last Update Submit

February 8, 2021

Conditions

Cost of ICU

Outcome Measures

Primary Outcomes (1)

  • Cost of ICU

    Cost of ICU

    1 month

Study Arms (2)

Before SARS-Cov2

Before SARS-Cov2

Other: Cost

After SARS-Cov2

After SARS-Cov2

Other: Cost

Interventions

CostOTHER

ICU cost

After SARS-Cov2Before SARS-Cov2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients hospitalized in intensive care in the last 3 months of 2019 and all SARS-Cov2 patients hospitalized in intensive care in the last 3 months of 2020.

You may qualify if:

  • Above 18 years old
  • All patients in intensive care unit in last three months of 2019
  • All SARS-Cov2 patients in intensive care unit in last three months of 2020

You may not qualify if:

  • Under 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Khan AA, AlRuthia Y, Balkhi B, Alghadeer SM, Temsah MH, Althunayyan SM, Alsofayan YM. Erratum: Khan, A.A., et al. Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia (Short Title: COVID-19 Survival and Cost in Saudi Arabia). Int. J. Environ. Res. Public Health 2020, 17, 7458. Int J Environ Res Public Health. 2020 Dec 17;17(24):9458. doi: 10.3390/ijerph17249458.

    PMID: 33348933RESULT

Related Links

MeSH Terms

Interventions

Costs and Cost Analysis

Intervention Hierarchy (Ancestors)

EconomicsHealth Care Economics and Organizations

Central Study Contacts

Ilke Kupeli

CONTACT

+90 555 548 5632ilkeser2004@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 8, 2021

First Posted

February 10, 2021

Study Start

February 15, 2021

Primary Completion

March 15, 2021

Study Completion

March 30, 2021

Last Updated

February 10, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share